The Checkup by Singlecare
MAY 9, 2025
Currently, Qulipta is not available as a generic medicine. RELATED: How much is Qulipta without insurance? Qulipta ( atogepant ) is a brand-name prescription medication used to prevent migraine headaches (both chronic and episodic migraines ). Qulipta is a type of calcitonin gene-related peptide ( CGRP ) receptor antagonist.
PharmTech
JULY 24, 2025
Meanwhile, the generic producers which I understand make up approximately 90% of US drug sales and have very thin profit margins to begin with. There's a limited ability to raise prices because of the reimbursement system and the insurance system and how drugs are paid for in our market. Policies and levels and insurance, right?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 18, 2025
Amid President Donald Trump’s stated desire to sharply reduce drug prices on the US market, India has also proposed to supply generic medicines at between 20% and 25% of the current reference branded prices, for three years after originator patent expiry. Give your business an edge with our leading industry insights.
STAT
JANUARY 5, 2024
As a former editor for diabetes publications, I knew that insurance companies regularly switched people from one brand of insulin to another, or from a name brand of insulin to a generic. However, I had used generic medicine for my blood pressure without a problem, so I hoped for the best with this switch.
STAT
FEBRUARY 5, 2024
Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.
The Checkup by Singlecare
OCTOBER 8, 2024
Without insurance, the cost of Xigduo XR varies by dosage, averaging about $390 per month, but there are ways to make it more affordable. Is there a generic for Xigduo XR? People often look for generic versions of medications to save on costs. Is Xigduo XR covered by insurance? 5 mg–1,000 mg versus 10 mg–500 mg).
pharmaphorum
JANUARY 13, 2022
Over the same period, total gross expenditures on brand and generic medicines nearly doubled – from $268 billion to $517 billion, according to the report. Growth in spending on branded medicines was driven “primarily by increases in payers’ statutory and negotiated rebates and fees,” it says.
Expert insights. Personalized for you.
Let's personalize your content